Materialise (Euronext and NASDAQ: MTLS) began 2026 with secure income, stronger margins, and higher working revenue, helped by development in medical and improved profitability in software program. The Belgian 3D printing firm additionally continued reshaping components of its manufacturing enterprise because it places extra give attention to medical, software program, and different steadier areas of additive manufacturing (AM).
Shares of Materialise fell roughly 4% following the earnings launch, with MTLS buying and selling between $5.34 and $5.45 in morning buying and selling, even after the corporate reported stronger margins and improved working revenue.
Printed, molded components are eliminated for additional processing on the ACTec foundry. Picture courtesy of Materialise.
For the primary quarter of 2026, Materialise reported income of €66.3 million, almost unchanged from €66.4 million throughout the identical interval final yr. Whereas total income stayed flat, Materialise mentioned development in its medical enterprise was partly offset by continued weak spot in manufacturing, notably in automotive and prototyping demand.
The corporate’s medical section was the strongest performer. Medical income rose 6.7% to €33.2 million, in comparison with €31.1 million a yr earlier. The section stays Materialise’s largest enterprise and certainly one of its most essential development areas, helped by demand for customized medical units, surgical planning instruments, and hospital-based 3D printing functions.
Materialise’s new customized PEEK CMF implant. Picture courtesy of Materialise.
Materialise’s software program income was weaker, slipping 1.4% to €9.6 million from €9.8 million a yr in the past, although the corporate mentioned overseas change strain from the weaker U.S. greenback affected outcomes through the quarter. On a constant-currency foundation, Materialise mentioned software program income would have grown yr over yr. Profitability within the section additionally improved sharply, with adjusted EBITDA rising 87.4% to €1.1 million.
Manufacturing was the weakest section. Income fell 8.1% to €23.5 million, down from €25.5 million within the first quarter of 2025. Even so, the section’s adjusted EBITDA improved to €281,000, in comparison with a lack of €377,000 a yr earlier.
Manufacturing was the weakest section. Income fell 8.1% to €23.5 million, down from €25.5 million within the first quarter of 2025, reflecting continued weak spot in automotive and prototyping demand. Nonetheless, the enterprise improved sequentially in comparison with the earlier three quarters, helped by development in aerospace, protection, and semiconductor functions. The section’s adjusted EBITDA additionally improved to €281,000, in comparison with a lack of €377,000 a yr earlier.
In Q1, the agency reported a internet revenue of €1.8 million, or 3 cents per share, in comparison with a loss throughout the identical interval final yr. The corporate additionally mentioned stronger margins and tighter price controls helped enhance total profitability through the quarter.
Brigitte de Vet-Veithen from Materialise speaks at AMS 2025. Picture courtesy of 3DPrint.com
In keeping with CEO Brigitte de Vet-Veithen, the corporate continues to see very completely different circumstances throughout industries and areas. Europe, notably the automotive sector, stays smooth, whereas aerospace and protection are displaying stronger momentum.
“In our aerospace market, we see additional investments in our finish markets that additionally profit the additive business, together with us. Protection is one other business the place budgets are being freed up now and the place we see constructive dynamics. It’s a really numerous image the place the U.S. markets are displaying a extra constructive development than the European markets,” famous de Vet-Veithen throughout an earnings name with traders.
Materialise CEO Brigitte de Vet-Veithen at Additive Manufacturing Methods 2024. Picture courtesy of 3DPrint.com/Ashley Alleyne.
Materialise additionally introduced the spin-offs of each its RapidFit and Eyewear companies, transferring the operations to their respective administration groups as unbiased corporations. RapidFit focuses on 3D printed jigs, fixtures, and high quality management instruments for the automotive business. Through the years, the enterprise grew right into a specialised manufacturing operation serving automotive clients with customized tooling and inspection options. Eyewear, in the meantime, developed right into a separate consumer-focused enterprise centered on custom-made 3D printed eyewear merchandise.
In keeping with Materialise, each companies will proceed working below their current management groups, giving them extra flexibility to give attention to their very own markets whereas permitting Materialise to pay attention extra closely on its core software program, medical, and manufacturing operations. The corporate mentioned the modifications will assist the companies function “nearer to its clients and markets” as they enter “their subsequent part of development.”
Together with the operational modifications, Materialise continued its share buyback program through the quarter. It ended the interval with a internet money place of €72.8 million, up from €71.3 million on the finish of 2025.
Materialise HQ in Belgium. Picture courtesy of Materialise.
The outcomes come at a time when a lot of the 3D printing business remains to be coping with slower industrial spending and weaker buyer demand. A number of publicly traded AM corporations have spent the final two years slicing prices, reorganizing components of their companies, or focusing extra on markets which have remained steadier.
For Materialise, healthcare continues to play a significant function in that technique. Medical functions stay one of the commercially established components of the 3D printing business, notably in areas like surgical guides, customized units, and hospital-based manufacturing. In the course of the quarter, the corporate expanded its medical portfolio with new patient-specific PEEK implants and launched OrthoView 3D Hip, a CT-based surgical planning platform for hip procedures.
The truth is, de Vet-Veithen mentioned the corporate stays centered on integrating new instruments right into a single workflow for hospitals and surgeons: “Till now, surgeons working with Materialise had titanium as their patient-specific choice. With this launch, they’ve an extra alternative. The brand new providing integrates seamlessly into our current digital workflow and completes our providing.
She then added that “the healthcare market at massive globally stays a wholesome atmosphere. The exception can be educational markets, the place we see primarily within the U.S., the impression of funding cuts which have been issued already final yr, they usually’re persevering with this yr.”
L-R: Dominic Stoerkle, Evonik; Bryan Dow, Cantor Fitzgerald; Brigitte de Vet-Veithen, Materialise; Joe Calmese, ADDMAN; Matteo Rigamonti, Weerg. Picture courtesy of 3DPrint.com.
On the similar time, the corporate seems more and more centered on enhancing effectivity throughout the enterprise. Whereas income was principally flat through the quarter, larger margins and stronger adjusted EBIT confirmed indicators of higher operational efficiency.
For the total yr, Materialise reaffirmed its 2026 steerage. The corporate expects income for the yr between €273 million and €283 million, with adjusted EBIT anticipated to vary between €10 million and €12 million.
Subscribe to Our Electronic mail Publication
Keep up-to-date on all the most recent information from the 3D printing business and obtain data and gives from third occasion distributors.
Add your 3D Fashions and get them printed rapidly and effectively.
